The GeneSight test is a pharmacogenomic test that analyzes clinically important genetic variations that may impact how your patient metabolizes or responds to certain medications.
The clinical validity, clinical utility, and economic utility of the GeneSight Psychotropic test have been evaluated in multiple published, peer-reviewed trials. It is the only psychiatric pharmacogenomic test backed by such extensive research.
In the GUIDED Study – the largest pharmacogenomic randomized controlled trial in mental health – GeneSight outperformed TAU on clinical endpoints. *
Directional improvement in symptoms at week 8 compared to TAU
Significantly higher response rates at week 8 compared to TAU
Significantly higher remission rates at week 8 compared to TAU
We Bill Your Insurance for the cost of the GeneSight test.
Medicare (Part B) Covered Tests — You will have a $0 out of pocket cost.
Medicare Advantage Covered Tests — You may be expected to cover a portion of the cost (typically $330 or less) and the GeneSight Promise applies.
Medicaid — Typically, you will have a $0 out of pocket cost.
Commercial or Other Insurance — Plans vary, but you may be expected to cover a portion of the cost (typically $330 or less) and the GeneSight Promise applies.
Uninsured — Please contact us to find out how we can help.
For more information, visit https://genesight.com/cost/.
Insurance can be complicated, and we want your patients to be comfortable knowing what they’ll owe. We promise that if their cost could be more than $330, we’ll call them before we process their test.
Step 1: A buccal swab is used to quickly collect a sample of your patient’s DNA. Just put the swabs in the prepaid FedEx envelope and send to our lab.
Step 2: Go to MyGeneSight.com to place the order.
Step 3: About 2 days after we receive the sample, you can access your patient’s personalized report on the secure GeneSight website.
“Knowing a little bit more about your patient than what you can gleam just from their evaluation, initial consultation, and history is very useful.” (Antonio de Filippo, MD)
"Quite simply, I use the GeneSight test because people are suffering. I do not want someone to leave my office feeling worse - I want people to leave feeling better. I always fight for my patients to get better." (F. Ada N. Ifesinachukwu, MD)
"I'm using scientific data to make decisions rather than just trial and error." (Carlo Bayrakdarian, MD)
*Greden JF, et al. Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study, Journal of Psychiatric Research (2019), doi: https://doi.org/10.1016/j.jpsychires.2019.01.003
Not all patients who receive the GeneSight test will experience improvements in symptoms, achieve response, or achieve remission.
The Montana Psychiatry Conference makes every attempt to provide accurate and timely content available for users. Neither MPC nor third-party content providers are responsible or liable for any such content, including advertising, products or other materials available through third party sites.